← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mycologics, Inc.
Aurora, CO
$1,425,919
Total funding
12
Grants
Funding over time
peak $102K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$1,425,919 · 12
By mechanism
R43$899,576 · 9
R44$324,394 · 1
R41$201,949 · 2
Investigators at Mycologics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
SCREENING OF THERMOPHILES FOR ANTIFUNGAL ACTIVITY$324,394
R44 · FY2000 · AI
Leishmania major nucleoside hydrolase inhibitors$101,950
R41 · FY2007 · AI
Antifungal drugs: Beta(1,6)-glucan synthesis inhibitors$100,000
R43 · FY2003 · AI
The glyoxylate cycle as a new target for antifungals$100,000
R43 · FY2003 · AI
New drugs for the treatment of leishmaniasis$100,000
R43 · FY2004 · AI
A NOVEL SCREEN FOR INHIBITORS OF FUNGAL GPI-ANCHORING$100,000
R43 · FY2002 · AI
Inhibitors of transcription of fungal glucan synthase$100,000
R43 · FY2003 · AI
A novel vaccine against Leishmania$100,000
R43 · FY2005 · AI
A novel recombinant vaccine against Cryptococcus.$99,999
R41 · FY2004 · AI
A novel yeast vaccine against Coccidioides Immitis$99,997
R43 · FY2003 · AI
A novel vaccine for Aspergillus fumigatus$99,997
R43 · FY2003 · AI
A NOVEL ANTIFUNGAL COMPOUND FROM CAYENNE PEPPER$99,582
R43 · FY2001 · AI